| Product NDC: | 13668-151 | 
| Proprietary Name: | QUETIAPINE FUMARATE | 
| Non Proprietary Name: | QUETIAPINE FUMARATE | 
| Active Ingredient(s): | 200 mg/1 & nbsp; QUETIAPINE FUMARATE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 13668-151 | 
| Labeler Name: | Torrent Pharmaceuticals Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA200363 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120327 | 
| Package NDC: | 13668-151-74 | 
| Package Description: | 100 TABLET in 1 CARTON (13668-151-74) | 
| NDC Code | 13668-151-74 | 
| Proprietary Name | QUETIAPINE FUMARATE | 
| Package Description | 100 TABLET in 1 CARTON (13668-151-74) | 
| Product NDC | 13668-151 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | QUETIAPINE FUMARATE | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20120327 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Torrent Pharmaceuticals Limited | 
| Substance Name | QUETIAPINE FUMARATE | 
| Strength Number | 200 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |